業績｜論文・出版物｜目次｜ALL

Evaluation of immune response after administration of plasmid DNA-non-viral vector complexes

Sakurai F., Takakura Y., Hashida M.

Gene Design and Delivery, Springer, Non-viral Gene Therapy, 339-347 (2005)

WebSite

目的遺伝子の抑制レベルを自由に制御するアデノウイルスベクターの開発

水口裕之

実験医学, 羊土社, 23, 2167-2172 (2005)

WebSite

改良型アデノウイルスベクターを用いた造血幹細胞, 間葉系幹細胞, ES細胞への高効率遺伝子導入

水口裕之, 川端健二, 櫻井文教, 早川堯夫

炎症・再生, 25, 447-451 (2005)

J-STAGE

カプシドタンパク質を改変した改良型アデノウイルスベクターによる高効率遺伝子導入

水口裕之, 早川堯夫

BIO INDUSTRY, シーエムシー出版, 22, 16-21 (2005)

WebSite

ウイルスベクター

水口裕之, 早川堯夫

Drug Delivery System, 日本DDS学会, 20, 158-159 (2005)

CiNii

高性能な遺伝子導入ベクターの開発を目指して

櫻井文教

Drug Delivery System, 日本DDS学会, 20, 474-475 (2005)

CiNii

ウイルスベクターのＤＤＳ

水口裕之

Drug Metabolism and Pharmacokinetics, 19, 30-32 (2005)

CiNii

Targeted adenovirus vectors

Mizuguchi H., Hayakawa T.

Hum. Gene Ther., 15, 1034-1044 (2004)

PubMed

Adenovirus vector-mediated doxycycline-inducible RNA interference

Hosono T., Mizuguchi H., Katayama K., Xu ZL., Sakurai F., Ishii-Watabe A., Kawabata K., Yamaguchi T., Nakagawa S., Mayumi T., Hayakawa T.

Hum. Gene Ther., 15, 813-819 (2004)

PubMed

Efficient gene transfer into human trophoblast cells with adenovirus vector containing chimeric type 5 and 35 fiber protein

Koizumi, N., Mizuguchi H., Kondoh, M., Fujii, M., Hayakawa, T., Watanabe, Y.

Biol. Pharm. Bull., 27, 2046-2048 (2004)

PubMed

An improved method for detection of replication-competent retrovirus in retrovirus vector products

Uchida E., Sato K., Iwata A., Ishii-Watabe A., Mizuguchi H., Hikata M., Murata M., Yamaguchi T., Hayakawa T.

Biologicals, 32, 139-146 (2004)

PubMed

High gene expression of the mutant adenovirus vector, both in vitro and in vivo, with the insertion of integrin-targeting peptide into the fiber

Gao J-Q., Inoue S., Tsukada Y., Katayama K., Eto Y., Kurachi S., Mizuguchi H., Hayakawa T., Tsutsumi Y., Mayumi T., Nakagawa S.

Pharmazie, 59, 571-572 (2004)

PubMed

Simultaneous imaging of initiator/effector caspase activity and mitochondrial membrane potential during cell death in living HeLa cells

Kawai H., Suzuki T., Kobayashi T., Mizuguchi H., Hayakawa T., Kawanishi T.

Biochim. Biophys. Acta, 1693, 101-110 (2004)

PubMed

Neutralizing antibody evasion ability of adenovirus vector induced by the bioconjugation of methoxypolyethylene glycol succinimidyl propionate (MPEG-SPA)

Eto Y., Gao J-Q., Sekiguchi F., Kurachi S., Katayama K., Mizuguchi H., Hayakawa T., Tsutsumi Y., Mayumi T., Nakagawa S.

Biol. Pharm. Bull., 27, 936-938 (2004)

PubMed

Antibody-targeted cell fusion

Nakamura T., Peng K-W., Vongpunsawad S., Harvey M., Mizuguchi H., Hayakawa T., Cattaneo R., Russell S.J.

Nat. Biotech., 22, 331-336 (2004)

PubMed

Optimization of antitumor efficacy and safety of in vivo cytokine gene therapy using RGD fiber-mutant adenovirus vector for preexisting murine melanoma

Okada Y., Okada N., Mizuguchi H., Takahashi K., Hayakawa T., Mayumi T., Mizuno N.

Biochim. Biophys. Acta, 1670, 172-180 (2004)

PubMed

Anti-tumor activity of chemokine is affected by both kinds of tumors and the activation state of the host's immune system: implications for chemokine-based cancer immunotherapy

Okada N., Gao J-Q., Sasaki A., Niwa M., Okada Y., Nakayama T., Yoshie O., Mizuguchi H., Hayakawa T., Fujita T., Yamamoto A., Tsutsumi Y., Mayumi T., Nakagawa S.

Biochem. Biophys. Res. Commun., 317, 68-76 (2004)

PubMed

Overexpression of constitutively activated glutamate dehydrogenase induces insulin secretion through enhanced glutamate oxidation

Anno T., Uehara S., Katagiri H., Ohta Y., Ueda K., Mizuguchi H., Moriyama Y., Oka Y., Tanizawa Y.

Am. J. Physiol., 286, E280-285 (2004)

PubMed

Tumor-suppressive activities by chemokines introduced into OV-HM cells using fiber-mutant adenovirus vectors

Gao J-Q, Alexandre L.S., Tsuda Y., Katayama K., Eto Y., Sekiguchi F., Mizuguchi H., Hayakawa T., Nakayama T., Yoshie O., Tsutsumi Y., Mayumi T., Nakagawa S.

Pharmazie, 59, 238-239 (2004)

PubMed

RNA interfering approach for clarifying PPARγ pathway using lentiviral vector expressing short hairpin RNA

Katayama K., Wada K., Miyoshi H., Ohashi K., Tachibana M., Furuki R., Mizuguchi H., Hayakawa T., Nakajima A., Kadowaki T., Tsutsumi Y., Nakagawa1 S., Kamisaki Y., Mayumi T.

FEBS Lett., 560, 178-182 (2004)

PubMed

目次に戻る

大阪大学大学院薬学研究科分子生物学分野

Laboratory of Biochemistry and Molecular Biology

Graduate School of Pharmaceutical Sciences, Osaka University

業績｜論文・出版物｜目次｜ALL